Cutler Group LP Mesoblast LTD Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Jul 19, 2021	BUY	$6.69 - $9.0 $13,380 - $18,000	2,000 Added 125.0%	3,600 $0
Q1 2021 Apr 26, 2021	SELL	$8.26 - $11.4 $58,646 - $80,940	-7,100 Reduced 81.61%	1,600 $2,000
Q4 2020 Jan 21, 2021	BUY	$8.21 - $18.59 $38,587 - $87,373	4,700 Added 117.5%	8,700 $35,000
Q3 2020 Oct 27, 2020	BUY	$11.33 - $19.81 $24,926 - $43,582	2,200 Added 122.22%	4,000 $3,000
Q2 2020 Jul 22, 2020	BUY	$4.2 - $15.45 $7,560 - $27,810	1,800 New	1,800 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.